Living recombinant Saccharomyces cerevisiae secreting proteins or peptides as a new drug delivery system in the gut

Journal of Biotechnology

Volumn 110, Issue 1, 2004, Pages 37-49

  Blanquet, Stéphanie ^a   Antonelli, Richard ^b   Laforet, Laurent ^b   Denis, Sylvain ^a   Marol Bonnin, Sylvie ^b   Alric, Monique ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Digestar SA   (France)

Author keywords

Artificial digestive system; Drug delivery; Recombinant Saccharomyces cerevisiae; Secretion

Indexed keywords

DISEASE CONTROL; GENES; POLYPEPTIDES; PROTEINS; YEAST;

PEPTIDES; SECRETING PROTEINS;

BIOTECHNOLOGY;

FUNGAL PROTEIN; GLUTATHIONE TRANSFERASE; RECOMBINANT PROTEIN;

ARTICLE; DRUG DELIVERY SYSTEM; FUNGAL STRAIN; FUNGUS CULTURE; GASTROINTESTINAL TRACT; GENE INDUCTION; ILEUM; JEJUNUM; MODEL; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SMALL INTESTINE; SURVIVAL RATE;

ANIMALS; BASE SEQUENCE; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL TRACT; GENETIC ENGINEERING; GLUTATHIONE TRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMIDS; PROTEIN BIOSYNTHESIS; PROTEINS; SACCHAROMYCES CEREVISIAE; TIME FACTORS;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 1942455767     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2004.01.012     Document Type: Article

References (37)

1. Blanquet S., Marol-Bonnin S., Beyssac E., Pompon D., Renaud M., Alric M. The Biodrug concept: an innovative approach to therapy. Trends Biotechnol. 19:2001;393-400.
2. Blanquet S., Meunier J.P., Minekus M., Marol-Bonnin S., Alric M. Recombinant Saccharomyces cerevisiae expressing a P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment. Appl. Environ. Microbiol. 69:2003;2884-2892.
3. Bourdonnais Y., Bolin D., Shields D. Secretion of somatostatin by Saccharomyces cerevisiae. Correct proteolytic processing of pro-α-factor- somatostatin hybrids requires the products of the KEX2 and STE13 genes. J. Biol. Chem. 263:1988;15342-15347.
4. Brake A.J., Merryweather J.P., Coit D.G., Heberlein U.A., Masiarz F.R., Mullenbach G.T., Urdea M.S., Valenzuela P., Baar P.J. α-factor-directed synthesis and secretion of mature proteins in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 81:1984;4642-4646.
5. Brake A.J. α-factor leader-directed secretion of heterologous proteins from yeasts. Methods Enzymol. 185:1990;408-421.
6. Bumann D., Hueck C., Aebisher T., Meyer T.F. Recombinant live Salmonella spp. for human vaccination against pathogens. FEMS Immunol. Med. Microbiol. 27:2000;357-364.
7. Chang T.M., Prakash S. Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today. 4:1998;221-227.
8. Chatel J.M., Langella P., Adel-Patient K., Commissaire J., Wal J.M., Corthier G. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin. Diagn. Lab. Immunol. 8:2001;545-551.
9. Chen C.M., Cheng W.T.K., Chang Y.C., Chang T.J., Chen H.L. Growth enhancement of fowls by dietary administration of recombinant yeast cultures containing enriched growth hormones. Life Sci. 67:2000;2102-2115.
10. Corthier, G., Renault, P., 1999. Future directions for research on biotherapeutic agents: contribution of genetic approaches on lactic acid bacteria. In: Elmer, G.W., McFarland, L., Surawicz, C. (Eds.), Biotherapeutic Agents and Infection Diseases, Humana Press, Totowa, NJ, pp. 269-304.
11. Drouault S., Corthier G., Ehrlich S.D., Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65:1999;4881-4886.
12. Drouault S., Juste C., Marteau P., Renault P., Corthier G. Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl. Environ. Microbiol. 68:2002;3166-3168.
13. Duke, R.C., Franzusoff, A., Bellgrau, D., 1996. Yeast-based delivery vehicles. Int patent W0 96/14876.
14. Fahl, W.E., Loo, D., Manoharan, H., 1999. Chemoprotective bacterial strains. Int patent WO 99/27953.
15. Gietz D.R., St. Jean A., Woods R.A., Schiestl R.H. Improved method for high efficiency transformation of intact yeasts cells. Nucleic Acids Res. 20:1992;1425.
16. Guisez Y., Tison B., Vandekerckhove J., Demolder J., Bauw G., Haegeman G., Fiers W., Contreras R. Production and purification of recombinant interleukin-6 secreted by the yeast Saccharomyces cerevisiae. Eur. J. Biochem. 198:1991;217-222.
17. Kjeldsen T. Yeast secretory expression of insulin precursors. Appl. Microbiol. Biotechnol. 54:2000;277-286.
18. Krul C.A.M., Luiten-Schuite A., Baan R., Verhagen H., Mohn G., Feron V., Havenaar R. Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food Chem. Toxicol. 38:2000;783-792.
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
20. Larsson M., Minekus M., Havenaar R. Estimation of the bioavailability of iron and phosphorus in cereals using a dynamic in vitro gastro-intestinal model. J. Sci. Food Agric. 74:1997;99-106.
21. Longtine M.S., McKenzie A., Demarini D.J., Shah N.G., Wach A., Brachat A., Philippsen P., Pringle J.R. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast. 14:1998;953-961.
22. Marteau P., Minekus M., Havenaar R., Huis in't Veld J.H.J. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of the bile. J. Dairy Sci. 80:1997;1031-1037.
23. Minekus M., Marteau P., Havenaar R., Huis in't Veld J.H.J. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. Atla. 23:1995;197-209.
24. Molin S. Environmental potential of suicide genes. Curr. Opin. Biotechnol. 4:1993;299-305.
25. Nayak A.R., Tinge S.A., Tart R.C., McDaniel L.S., Briles D.E., 3rd Curtiss R. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect. Immunol. 66:1998;3744-3751.
26. Oldenburg K.R., Vo T.K., Michaelis S., Paddon C. Recombination-mediated PCR-directed plasmid construction in vivo in yeast. Nucleic Acids Res. 25:1997;451-452.
27. Oozeer R., Goupil-Feuillerat N., Alpert C.A., Van de Guchte M., Anba J., Mengaud J., Corthier G. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl. Environ. Microbiol. 68:2002;3570-3574.
28. Pouwels P.H., Leer R.J., Shaw M., Bak-Glashouwer M.J.H.D., Tielen F.D., Smit E., Martinez B., Jore J., Conway P.L. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food. Microbiol. 41:1998;155-167.
29. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M., Le Page R.W.F. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:1997;653-657.
30. Schägger H., Jagow G.V. Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for separation of proteins in the range from 1 to 100. kDa Anal. Biochem. 166:1987;368-379.
31. Schreuder M.P., Deen C., Boersma W.J.A., Pouwels P.H., Klis F.M. Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine. 14:1996;383-388.
32. Schultz L.D., Tanner J., Hofmann K.F., Emini E.A., Condra J.H., Jones R.E., Kieff E., Ellis R.W. Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus. Gene. 54:1987;113-123.
33. Singh A., Lugovoy J.M., Kohr W.J., Perry L.J. Synthesis, secretion and processing of alpha-factor-interferon fusion proteins in yeast. Nucleic Acids Res. 12:1984;8927-8938.
34. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., Remaut E. Treatment of murine colitis by Lactococcus lactis secreting Interleukin-10. Science. 289:2000;1352-1355.
35. Steidler L. Microbiological and immunological strategies for treatment of inflammatory bowel disease. Microbes Infect. 3:2001;1157-1166.
36. Verwei M., Arkbage K., Havenaar R., Van den Berg H., Witthöft C., Schaafsma G. Folic acid and 5-methyl-tetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J. Nutr. 133:2003;2377-2383.
37. Zsebo K.M., Lu H.S., Fieschko J.C., Goldstein L., Davis J., Duker K., Suggs S.V., Lai P.H., Bitter G.A. Protein secretion from Saccharomyces cerevisiae directed by the prepro-α-factor leader region. J. Biol. Chem. 261:1986;5858-5865.